Form 4 for NEO NEOGENOMICS INC
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-01 · accession 0001077183-25-000123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-03 | 2025-06-01 | NEO | Zook Anthony P. | CEO, Dir | M - OptEx | $0.00 | +12.3K | 23.6K | +108% | $0 |
| D | 2025-06-03 | 2025-06-01 | NEO | Zook Anthony P. | CEO, Dir | F - Tax | $0.00 | -3,424 | 20.2K | -15% | $0 |
| D | 2025-06-03 | 2025-06-01 | NEO | Zook Anthony P. | CEO, Dir | M - OptEx | $0.00 | -12.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-01 | M | A | 12,254 | $0.00 | 23,590 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. |
| 2 | Common | Common Stock | 2025-06-01 | F | D | 3,424 | $0.00 | 20,166 | D | — | — | (F2) Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2024 vesting of restricted stock. |
| 3 | Derivative | Restricted Stock Unit | 2025-06-01 | M | D | 12,254 | $0.00 | 0 | D | $0.00 · 2025-06-01 to — | 12,254 Common Stock | (F3) Once vested, the shares of common stock are not subject to expiration. |